A Phase 1 clinical trial shows the noninvasive technique is safe and could aid in the delivery treatments to the brain.

Researchers use a combination of ultrasound waves, genetic engineering, and synthetic drugs to switch specific neurons on and off in mice.

To treat neurological disease, researchers develop techniques to bypass or trick the guardian of the central nervous system.

The blood-brain barrier is a collection of specialized cells and proteins that control the movement of molecules from the blood to the central nervous system.

Scientists designed autonomous nanovesicles capable of following glucose concentration gradients, even through the blood brain barrier in rats.